PhD fellowship in antibody-drug conjugate (ADC)… | StemSkills Lab
Skip to content
Closed

PhD fellowship in antibody-drug conjugate (ADC) engineering: internalization and lysosomal delivery

University of Copenhagen (Koebenhavns Universitet), Biotech Research and Innovation Centre (BRIC) / Finsen Laboratory · More from University of Copenhagen

This deadline has passed. The record is kept here so you can plan for the next round. See the opportunities that are open now.

Missed this round?

Get told when the next round opens

We read University of Copenhagen (Koebenhavns Universitet), Biotech Research and Innovation Centre (BRIC) / Finsen Laboratory's own website. When a new round is listed, you get one email.

Who can apply

  • An MSc (120 ECTS or equivalent) in pharmaceutical biotechnology, biotechnology or a closely related field, with an MSc thesis on antibody-drug conjugates or antibody-based cancer therapeutics and hands-on experience in antibody production, payload conjugation, cytotoxicity assays, flow cytometry and laboratory animal work. The master's degree must be equivalent to a Danish master's degree. Excellent written and spoken English is required.

What is funded

A salaried 3-year PhD fellowship at BRIC, part of a Novo Nordisk Foundation Distinguished Innovator project. Salary and pension follow the Danish state agreement for academics. Expected start is 15 January 2027.

Stage dates

show=171624

Online application via Apply now, 23.59 CET6 November 2026

Interviews expected in week 49 (2026)See the official page

Start 15 January 2027 or after agreement15 January 2027

Dates come from the funder's page for this round. When a round closes, the next round's dates replace these once the funder publishes them.

All verified opportunities

See live workshops